TEDD Competence Centre
Collaborative innovation platform, dedicated to 3D cell culture technology and organ-like tissue models for drug development, substance testing, personalized and regenerative medicine.
Partner Highlight
TEDD Annual Meeting 2019
Primary and stem cells are becoming important sources for the generation of organotypic tissue models used in many biopharmaceutical applications, regenerative medicine, disease modelling and drug discovery. During TEDD Annual Meeting 2019, we will discuss how stem cells have already been used in the drug discovery process and how novel technologies can be applied to attain widespread adoption of stem cell technology by the pharmaceutical and biotech industry. Several companies will exhibit during our famously long lunch break at the Greenhouse.
Call for Exhibition (PDF 350,3 KB): follow the link below for more details. Space is limited.
About TEDD
As an information and matchmaking hub, TEDD transfers knowledge and technologies in order to promote the development and application of 3D cell culture. The TEDD community is currently composed of partners from academia, clinical medicine and industry. The industrial partners represent the majority of TEDD partners, and comprise a spectrum from young spin-off company to world player. Thus, TEDD represents the entire value chain of biotech R&D relevant for 3D tissue engineering, be it ultraflat 3D monolayer culture, bioprinted tissue constructs, or organoids.
This might also interest you
Partnership
Who are our Partners? What are the benefits of joining our network? How to become a Partner of CC TEDD?
About
Partnership
Team
Learn more about vision, goals, competencies and history of CC TEDD.
Who are our Partners? What are the benefits of joining our network? How to become a Partner of CC TEDD?
Meet the team and board of the Competence Centre.